Body Weight Monitoring
Objective: Track body weight changes and monitor diabetes onset in creatine-supplemented versus control transgenic mice (R6/2 line) to assess neuroprotective effects of dietary creatine supplementation
This is a Body Weight Monitoring protocol using mouse as the model organism. The procedure involves 5 procedural steps, 2 equipment items, 1 materials. Extracted from a 2000 paper published in Journal of Neuroscience.
Model and subjects
mouse • R6/2 transgenic • unknown • Not specified • Not specified
Study window
Estimated timing pending
Core workflow
Establish treatment groups • Administer dietary creatine supplementation • Monitor body weight
Primary readouts
- Body weight changes over time
- Onset and timing of diabetes development
- Motor performance on rotarod test
- Survival rates
Key equipment and reagents
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
- Verify the animal model, intervention setup, and collection timepoints against the source paper.
- Check that every direct vendor link matches the exact specification your lab plans to run.
Use the page like this
- Work through the protocol steps in order and use the inline vendor chips only when you need to source or verify an item.
- Jump to Experimental Context for readouts, data shape, and analysis flow before planning downstream analysis.
Protocol Steps
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Establish treatment groups
Divide R6/2 transgenic mice into creatine-supplemented and control groups
Note: Study compares creatine-supplemented R6/2 mice versus control R6/2 mice
View evidence from paper
“creatine-supplemented R6/2 mice, whereas the onset of diabetes was markedly delayed”
Administer dietary creatine supplementation
Provide creatine supplementation to treatment group through diet
Note: Control group receives standard diet without creatine supplementation
View evidence from paper
“Dietary creatine supplementation significantly improved survival, slowed the development of brain atrophy”
Monitor body weight
Regularly measure and track body weight changes in both creatine-supplemented and control mice
Note: Body weight is a key outcome measure for assessing disease progression
View evidence from paper
“Body weight and motor performance on the rotarod test were significantly improved in creatine-supplemented R6/2 mice”
Monitor diabetes onset
Track and record the development and timing of diabetes in both treatment and control groups
Note: Diabetes onset is delayed in creatine-supplemented mice compared to controls
View evidence from paper
“the onset of diabetes was markedly delayed”
Perform rotarod motor performance testing
Assess motor coordination and balance using rotarod apparatus in both groups
Note: Motor performance is significantly improved in creatine-supplemented mice
View evidence from paper
“Body weight and motor performance on the rotarod test were significantly improved in creatine-supplemented R6/2 mice”